The innovative drug concept collectively declined. Lianhuan Pharmaceutical and Onlikang both fell to a standstill. Previously, Minovar fell to a standstill, Tianjin Pharmaceutical was close to a standstill, and Shu Taishen and Hualan shares fell by more than 11%, followed by Frontier Biology, Kangzhi Pharmaceutical, and Shuanglu Pharmaceutical.

Zhitongcaijing · 4d ago
The innovative drug concept collectively declined. Lianhuan Pharmaceutical and Onlikang both fell to a standstill. Previously, Minovar fell to a standstill, Tianjin Pharmaceutical was close to a standstill, and Shu Taishen and Hualan shares fell by more than 11%, followed by Frontier Biology, Kangzhi Pharmaceutical, and Shuanglu Pharmaceutical.